AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis

被引:10
|
作者
Huang, Chaoyuan [1 ]
Luo, Hu [1 ]
Huang, Yuancheng [1 ]
Fang, Chongkai [1 ]
Zhao, Lina [2 ]
Li, Peiwu [2 ]
Zhong, Chong [3 ]
Liu, Fengbin [2 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou, Peoples R China
[2] Guangzhou Univ Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Guangzhou Univ Chinese Med, Dept Gastroenterol, Baiyun Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2021年 / 14卷
基金
中国国家自然科学基金;
关键词
Scutellaria barbata; hepatocellular carcinoma; effector mechanism; network pharmacology; bioinformatics analysis; molecular docking; DIFFERENTIALLY EXPRESSED GENES; CELL-CYCLE REGULATION; KINASE; CANCER; PATHWAYS; SPINDLE;
D O I
10.2147/IJGM.S318077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aim to explore the potential anti-HCC mechanism of Scutellaria barbata through integrated bioinformatics analysis. Methods: We searched active ingredients and related targets of Scutellaria barbata via TCMSP database, PubChem and SwissTargetPrediction database. Then, we identified HCC disease targets from GEO dataset by WGCNA. Next, the intersected targets of disease targets and drug targets were input into STRING database to construct PPI networking in order to obtain potential therapeutic targets of Scutellaria barbata. Cytoscape software was used to carry out network topology analysis of potential targets. We used the R package for GO analysis and KEGG analysis. Finally, we used AutoDock vina and PyMOL software for molecular docking. Results: Sixteen active components from Scutellaria barbata were lastly selected for further investigation. A total of 442 component targets were identified from 16 active ingredients of Scutellaria barbata after the removal of duplicate targets. GSE45436 was selected for construction of WGCNA and screening of differentially expressed genes. A total of 354 genes were up-regulated in HCC samples and 100 were down-regulated in HCC patients. Twenty-one common genes were obtained by intersection and 10 critical targets were filtered for further investigation. The enrichment analysis showed that cell cycle, DNA replication, p53 signaling pathway were mainly involved. The molecular docking results showed that 4 potential combinations were with the best binding energy and molecular interactions. Conclusion: AURKB, CHEK1 and NEK2 could be the potential target proteins of Scutellaria barbata in treating HCC. Cell cycle, DNA replication, p53 signaling pathway consist of the fundamental regulation cores in this mechanism.
引用
收藏
页码:3295 / 3312
页数:18
相关论文
共 50 条
  • [31] An analysis of DKK1-CKAP4 signaling as a prognostic factor and potential therapeutic target of hepatocellular carcinoma
    Sada, Ryota
    Iguchi, Kosuke
    Matsumoto, Shinji
    Zen, Yoh
    Akita, Masayuki
    Gon, Hidetoshi
    Fukumoto, Takumi
    Kikuchi, Akira
    CANCER SCIENCE, 2025, 116 : 157 - 157
  • [32] TFCP2L1 Promoted Self-Renewal of Hepatocellular Carcinoma Cells Which Provided a Potential Therapeutic Target for Hepatocellular Carcinoma Treatment
    Qiu, Dongbo
    Jia, Changchang
    Yao, Zhicheng
    Huang, Zenan
    Lin, Zexiao
    Wang, Tiantian
    HEPATOLOGY, 2018, 68 : 1262A - 1262A
  • [33] Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker
    Li, Chuanfei
    Zhou, Di
    Jiang, Xiaoling
    Liu, Minhui
    Tang, Hui
    Mei, Zhechuan
    GENE, 2019, 698 : 9 - 18
  • [34] N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target
    Guo, Jinhui
    Zhao, Jie
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2023, 33 (08):
  • [35] Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
    Ma, Liang
    Li, Yuling
    Wu, Jingxian
    Gao, Yanfei
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [36] Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target
    Gong, Xiaoming
    Gong, Yahong
    Wu, Guifang
    Ke, Hengning
    MEDICINE, 2024, 103 (12) : E37609
  • [37] Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis
    Liu, Jinwei
    Yu, Zhaojin
    Sun, Mingli
    Liu, Qianqian
    Wei, Minjie
    Gao, Hua
    ONCOLOGY LETTERS, 2019, 18 (05) : 4778 - 4788
  • [38] Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation
    Liao, Hangyu
    Yang, Jun
    Xu, Yuyan
    Xie, Juncheng
    Li, Ke
    Chen, Kunling
    Pei, Jingyuan
    Luo, Qiong
    Pan, Mingxin
    CANCERS, 2023, 15 (19)
  • [39] Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells
    Chen, Chih-Ta
    Liao, Li-Zhu
    Lu, Ching-Hui
    Huang, Yung-Hsuan
    Lin, Yu-Kie
    Lin, Jung-Hsin
    Chow, Lu-Ping
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (03): : 497 - 513
  • [40] Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells
    Chih-Ta Chen
    Li-Zhu Liao
    Ching-Hui Lu
    Yung-Hsuan Huang
    Yu-Kie Lin
    Jung-Hsin Lin
    Lu-Ping Chow
    Experimental & Molecular Medicine, 2020, 52 : 497 - 513